Skip to content

Released Mar 24, 2014, after the close

10-Q filed Mar 24, 2014, 267 days after period end · 0001193125-14-112535

Q2 2013 · 10-Q
Revenue$97.64M−12.5% vs Q2 2012−4.5% vs Q1 2013
Net Income-$3.01MN/M vs Q2 2012N/M vs Q1 2013
EPS Diluted-$0.16N/M vs Q2 2012N/M vs Q1 2013
Gross Profit$75,756,000−12.6%
Operating Income$6,920,000−58.4%
Operating Cash Flowderived$19,083,000+117.1%
Free Cash Flowderived$12,286,000+418.8%
Margins · derived
Gross margin77.6%−0.1 pt vs Q2 2012
Operating margin7.1%−7.8 pt vs Q2 2012
Net margin-3.1%−11.0 pt vs Q2 2012

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ2 2013Q2 2012Q2 2011Q2 2010
Revenue$97.64M$111.60M$108.22M$142.85M
Net Income-$3.01M$8.80M$5.40M$10.23M
EPS Diluted-$0.16$0.46$0.29$0.57

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR